Skip to main content
OpenTrials

Clinical trial condition

Colitis, Ulcerative

Explore clinical trials studying Colitis, Ulcerative. Study availability and eligibility vary by location and protocol.

1,249 public trials 241 recruiting studies
Refine in advanced search Browse all conditions

Colitis, Ulcerative trial results

Completed

ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1

NCT05507203

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Digestive Health Specialists of the Southeast Dothan, Alabama, United States
  • Lakeview Clinical Research Guntersville, Alabama, United States
  • GI Alliance Sun City, Arizona, United States
  • Del Sol Research Management, LLC Tucson, Arizona, United States
View all 320 locations
View Trial Details
Completed

ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2

NCT05507216

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • University of Alabama -Birmingham Birmingham, Alabama, United States
  • Research Solutions of Arizona, PC Litchfield Park, Arizona, United States
  • Valleywise Health Medical Center Phoenix, Arizona, United States
  • Reliance Research Scottsdale, Arizona, United States
View all 273 locations
View Trial Details
Completed

BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis

NCT03648541

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +5 more
Locations
  • Medical Research Center of Connecticut, LLC Hamden, Connecticut, United States
  • Emory University Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
  • Columbia University Medical Center-New York Presbyterian Hospital New York, United States
View all 38 locations
View Trial Details
Completed

A Study in Patients With Mild or Moderate Ulcerative Colitis Who Take a TNF Inhibitor. The Study Investigates Whether Bowel Inflammation Improves When Patients Take BI 655130 in Addition to Their Current Therapy

NCT03123120

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +5 more
Locations
  • Aalborg Sygehus Syd Aalborg, Denmark
  • Sanos Clinic Herlev, Denmark
  • Odense University Hospital Odense, Denmark
  • Universitätsklinikum Erlangen Erlangen, Germany
View all 16 locations
View Trial Details
Completed

BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis

NCT03482635

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +5 more
Locations
  • Medical Research Center of Connecticut, LLC Hamden, Connecticut, United States
  • University of Miami Miami, Florida, United States
  • AdventHealth Orlando Orlando, Florida, United States
  • Emory University Atlanta, Georgia, United States
View all 54 locations
View Trial Details
Completed

Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitis

NCT02632175

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Arnold Palmer Hospital /ID# 147295 Orlando, Florida, United States
  • MNGI Digestive Health, P. A. /ID# 147294 Minneapolis, Minnesota, United States
  • Mayo Clinic - Rochester /ID# 147304 Rochester, Minnesota, United States
  • MultiCare Institute Health System /ID# 169005 Tacoma, Washington, United States
View all 16 locations
View Trial Details
Completed

This Study Tests How BI 655130 Works in Patients With Active Ulcerative Colitis. The Study Also Tests How Well BI 655130 is Tolerated and Whether it Helps the Patients

NCT03100864

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +5 more
Locations
  • UZ Leuven Leuven, Belgium
  • Asklepios Kliniken Westklinikum Hamburg Hamburg, Germany
  • Universitätsklinikum Schleswig-Holstein, Campus Kiel Kiel, Germany
  • Addenbrooke's Hospital Cambridge, United Kingdom
View Trial Details
Completed

To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis

NCT03915769

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +8 more
Locations
  • Local Institution - 104 Sapporo, Hokkaido, Japan
  • Local Institution - 105 Nishinomiya, Hyōgo, Japan
  • Local Institution - 156 Okayama, Okayama-ken, Japan
  • Local Institution - 153 Osaka, Japan
View all 67 locations
View Trial Details

Related conditions